Blaine Labs Inc recalls

8 recalls.

• Revitaderm Wound Care recall (Blaine Labs Inc)
  DrugClass IIReported July 8, 2026 · CGMP Deviations; product manufactured in the same facility under the same conditions as the product found to be contaminated
• Fungal Fusion ERADICATION Solution recall (Blaine Labs Inc)
  DrugClass IIReported July 8, 2026 · CGMP Deviations; the firm discontinued required stability testing for products on the market still within expiry
• TERPENICOL Antifungal Solution recall (Blaine Labs Inc)
  DrugClass IIReported July 8, 2026 · CGMP Deviations; the firm discontinued required stability testing for products on the market still within expiry
• vite20 Antifungal Cream recall (Blaine Labs Inc)
  DrugClass IIReported July 8, 2026 · CGMP Deviations; the firm discontinued required stability testing for products on the market still within expiry
• TERPENICOL Antifungal Cream recall (Blaine Labs Inc)
  DrugClass IIReported July 8, 2026 · CGMP Deviations; the firm discontinued required stability testing for products on the market still within expiry
• TRIPENICOL S Antifungal Solution recall (Blaine Labs Inc)
  DrugClass IIReported July 8, 2026 · CGMP Deviations; the firm discontinued required stability testing for products on the market still within expiry
• TRIFLUENT PHARMA TRIDERGEL Wound Care Gel recall (Blaine Labs Inc)
  DrugClass IIReported July 8, 2026 · CGMP Deviations: product manufactured in the same facility under the same conditions as the product found to be contaminated
• Revitaderm Wound Care Gel recall (Blaine Labs Inc)
  DrugClass IReported July 8, 2026 · Microbial contamination of Non-Sterile Product: samples identified the presence of Lysinibacillus fusiformis and other Bacillus spp